New in Cancer: Joint series w/ @AnnSurgOncol on consensus guidelines for managing peritoneal surface malignancies from a multidisciplinary expert panel. 🎥 Watch an intro from @kturaga and explore the full collection: https://t.co/GN7AdMQgTd @OncoAlert @YaleMedicine

🎙️ CancerSpeak Mini Ep. 3: @ElizLGodfreyMD talks with Drs. White & Raoof about updated guidance on appendiceal tumors with peritoneal involvement—part of the PSM guideline series. 🎧 Listen: https://t.co/5rV2wlEf8U 📖 Read: https://t.co/jDGj3zVjy4 @oncoalert @YaleCancer

🔖 Also available in @AnnSurgOncol - https://t.co/2jRGINGTCB Countless thanks and huge congrats to the incredible #PSM Consortium Team 👩‍⚕️👨‍🔬👏 @kturaga @sbutensky @Varun_VBSurg @GomezJorgeMD @mtalhawaheed @ElizLGodfreyMD @KateBaronMD1 @FelipeLopezMD @Yale @YaleMed @YaleSurgery

📑 Immensely grateful to be part of @YaleMed #PSM Consortium team and work on this new guideline for #GastricCancer + #peritoneal mets - just out in @JournalCancer 📢 Huge thanks to @kturaga @sbutensky @Varun_VBSurg for the invitation 🤝 🔗 https://t.co/OvwMLqLfda @YaleSurgery

🎥 Sometimes, complete cytoreduction for #LAMN calls for bold moves - like this one, vibrantly featured by @ResearchSurgOnc team in @AnnSurgOncol 👩‍⚕️🧑‍⚕️ 🔪🔥 Your weekend CRS-#HIPEC must-watch: https://t.co/MxIoiSWnZ5 @VadimGushchin6 @MaryCaitKing @IugaiSergeiMD @ArmandoSardiMD

📊 What can an elevated pre-surgery #CRP tell about mucinous #AppendixCancer prognosis? Find out in the latest @ejsotweets publication by @ResearchSurgOnc team 👩‍🔬👨‍⚕️ Kudos to my amazing co-authors! 👏 🔖Full text: https://t.co/GGzXahsTr9 @VadimGushchin6 @ArmandoSardiMD

I was happy to present our study on the role of prior non-definitive surgery in #CRSHIPEC outcomes for #AppendixCancer patients. I hope this research contributes to raising awareness about peritoneal malignancies within the surgical community. Grateful to Dr. @RussellBrownMD for

Excited to present our @mfldclinic work on the feasibility of robotic CRS-#HIPEC 🔥 for low tumor burden #PSM and reconnect with friends and colleagues at #ACT2025 👩‍⚕🤝👨‍⚕ @SocSurgOnc

Happy #InternationalDayofWomenandGirlsinScience! Today, we celebrate the incredible women shaping the future of surgical oncology through research, innovation, and leadership. SSO is proud to support and uplift women in science! #SSOCommunity

Risk factors of a positive resection margin in locoregional #AppendixCancer and its impact on survival: The national cancer database analysis @KateBaronMD1 @ANikiforchin https://t.co/hpABkaUSDI @FlavioRochaMD @HalletJulie @SKMaithel @JulietOkoroh @TheNotoriousHPB

With proliferation of large databases research, it's inevitable that there's some misalignment of research ❓& dataset capabilities. Since I had to prep slides for 🗣️, thought I could share them if it's helpful for anyone conducting research or reviewing papers. A primer🧵:

👏 Kudos to phenomenal @KateBaronMD1 and incredible @mfldclinic #SurgOnc team for this outstanding @SurgOncInsight paper on risk factors and the impact of #ResectionMargin in stage I-III #AppendixCancer 🎗️ Perfect read for the weekend 📚 📑Open access: https://t.co/RS6IvF38EM

In Press: Discover how a positive #ResectionMargin worsens overall survival in locoregional #AppendixCancer in our recent #SurgicalOncologyInsight publication @KateBaronMD1 @ANikiforchin @mfldclinic https://t.co/BqX2OKw2E1 @FlavioRochaMD @DrMikeCavnar @SKMaithel @JulietOkoroh

🎥 Thrilled to share my first-ever teaching surgical video in @AnnSurgOncol featuring a complex #robotic resection of paraaortic #paraganglioma and its further management 🚀 Kudos to my incredible co-authors @KateBaronMD1, Dr. Wernberg, and Dr. Sharma 👏 https://t.co/H1xKHsYSBM

One of the best parts of #SSO2024 was getting to connect with old and new friends and awesome colleagues 🧡 @KateBaronMD1 I had missed you!

A lot of inspiration from bright and outstanding presentations at #SSO2024 in Atlanta. Congratulations @LFallaZuniga on an excellent talk. These days I was so happy to met new people as well as old friends.

Heading to #SSO2024 conference! Excited to learn from surgical oncology experts, see old friends, and present new data on #AppendixCancer and #PSM. Can't wait! @SocSurgOnc

We can't wait to see you in Atlanta for #SSO2024! Safe travels and see you soon!

Explore an example of overcoming #LMIC barriers & achieving standards in #PSM management ➡️ https://t.co/LvSXQgchMi #HIPEC @SKopetskyi @Marta_Antoniv @VadimGushchin6 @ANikiforchin #GlobalOnc

Incredible scientific debate on the hot and controversial topic - preoperative chemo in appendix cancer patients undergoing #HIPEC. Thank you Dr.@ArmandoSardiMD and Dr. Sameer Patel for the pleasure to watch. #ACT2024 🇵🇷